JP2022540433A5 - - Google Patents

Info

Publication number
JP2022540433A5
JP2022540433A5 JP2022500796A JP2022500796A JP2022540433A5 JP 2022540433 A5 JP2022540433 A5 JP 2022540433A5 JP 2022500796 A JP2022500796 A JP 2022500796A JP 2022500796 A JP2022500796 A JP 2022500796A JP 2022540433 A5 JP2022540433 A5 JP 2022540433A5
Authority
JP
Japan
Prior art keywords
alkyl
benzo
pentyl
chromen
trimethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2022500796A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022540433A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2020/050965 external-priority patent/WO2021007659A1/en
Publication of JP2022540433A publication Critical patent/JP2022540433A/ja
Publication of JP2022540433A5 publication Critical patent/JP2022540433A5/ja
Ceased legal-status Critical Current

Links

JP2022500796A 2019-07-12 2020-07-10 カンナビノイド誘導体 Ceased JP2022540433A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962873697P 2019-07-12 2019-07-12
US62/873,697 2019-07-12
PCT/CA2020/050965 WO2021007659A1 (en) 2019-07-12 2020-07-10 Cannabinoid derivatives

Publications (2)

Publication Number Publication Date
JP2022540433A JP2022540433A (ja) 2022-09-15
JP2022540433A5 true JP2022540433A5 (enExample) 2025-02-14

Family

ID=74209629

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022500796A Ceased JP2022540433A (ja) 2019-07-12 2020-07-10 カンナビノイド誘導体

Country Status (4)

Country Link
US (1) US20220242856A1 (enExample)
EP (1) EP3997084A4 (enExample)
JP (1) JP2022540433A (enExample)
WO (1) WO2021007659A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021007663A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
JP2022540586A (ja) 2019-07-12 2022-09-16 キャノピー グロウス コーポレイション カンナビノイド誘導体
US12252503B2 (en) 2019-07-12 2025-03-18 Canopy Growth Corporation Cannabinoid derivatives
WO2021062557A1 (en) * 2019-10-02 2021-04-08 Canopy Growth Corporation Cannabinoid derivatives
JP2022551066A (ja) 2019-10-02 2022-12-07 キャノピー グロウス コーポレイション カンナビノイド誘導体
WO2021102567A1 (en) 2019-11-26 2021-06-03 Canopy Growth Corporation Cannabigerol derivatives and use thereof as cannabinoid receptor modulators
US12240813B2 (en) 2020-05-19 2025-03-04 Cybin Irl Limited Deuterated tryptamine derivatives and methods of use
CA3205594A1 (en) 2020-12-17 2022-06-23 Nalu Bio, Inc. Synthesis of cannabidiol and analogs thereof, and related compounds, formulations, and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3325490A (en) * 1965-02-23 1967-06-13 Rexall Drug Chemical Substituted 1-hydroxydibenzopyrans
WO2006012176A1 (en) * 2004-06-24 2006-02-02 Virginia Commonwealth University Water-soluble cannabinoids
JP2009538827A (ja) * 2006-05-01 2009-11-12 イースタン バージニア メディカル スクール カンナビノイドおよび使用方法
WO2019234728A1 (en) * 2018-06-04 2019-12-12 Al&Am Pharmachem Ltd. Cannabinolic acid derivatives and uses thereof

Similar Documents

Publication Publication Date Title
JP2022540433A5 (enExample)
JP2023503331A5 (enExample)
JP2022540586A5 (enExample)
AU2013234009B2 (en) Heterocyclyl compounds as MEK inhibitors
ES2759949T3 (es) Compuestos heterocíclicos tricíclicos
KR101345473B1 (ko) 헤테로 화합물
EP2382212B1 (en) Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases
JP2022539401A5 (enExample)
JP5301286B2 (ja) Ｆｘ受容体を調節するための化合物及び方法
JP2022540432A5 (enExample)
CA2741839A1 (en) 1-oxa-8-azaspiro [4,5] decane-8-carboxamide compounds as faah inhibitors
JP2013508378A5 (enExample)
EP2370438A1 (en) Imidazo [1,2a]pyridine derivatives, their use as s1p1 agonists and methods for their production
CZ287771B6 (en) Dihydrobenzopyran derivatives, process and intermediates for their preparation, their use and pharmaceutical preparations based thereon
JP2022540585A5 (enExample)
JP2022540434A5 (enExample)
WO2010068452A1 (en) Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
JP2012515788A (ja) 自己免疫疾患および炎症性疾患の処置における、ｓ１ｐアゴニストとしての置換オキサジアゾール誘導体
HRP20171099T1 (hr) Derivati pirolo[2,3-d]pirimidina kao agonisti cb2 receptora
JP2013514280A (ja) スフィンゴシン１−リン酸１（ｓ１ｐ１）受容体アゴニストとして使用するためのオキサジアゾール置換インダゾール誘導体
AU2014352008B2 (en) Tricyclic piperidine compounds
ES2548683T3 (es) Amidas del ácido 4-(5-isoxazolil o 5-pirrazolil-1,2,4-oxadiazol-3-il)-mandélico como agonistas de receptor de esfingosina-1-fosfato 1
KR20160129089A (ko) 신규의 융합된 이미다조벤조티아졸 화합물
TW202233575A (zh) 用於治療與lpa受體活性相關的病狀的化合物及組合物
EP3071567A1 (en) Tricyclic imidazole compounds as inhibitors of tryptophan hydroxylase